TrialPain2019

SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain.

John Markman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.